Oxygenta Pharmaceutical
add_icon

Oxygenta Pharmaceutical

49.76
+1.77
(3.69%)
Market Cap
184.05 Cr
PE Ratio
-9.83
Volume
1,268.00
Day High - Low
49.80 - 45.36
52W High-Low
133.50 - 45.30
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
184.05 Cr
EPS
-2.69
PE Ratio
-9.83
PB Ratio
-4.84
Book Value
-9.92
EBITDA
-8.60
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
38.69
Debt to Equity
0.00
Forecast For
Actual

Company News

View All News
Caret
negative
Oxygenta Pharmaceutical Limited reported a net loss of ₹484.30 lakhs for Q3 FY26 ended December 31, 2025, compared to ₹392.82 lakhs loss in Q3 FY25, despite revenue growth to ₹3,393.09 lakhs.
neutral
Virupaksha Organics Limited acquired 1,95,885 equity shares of Oxygenta Pharmaceutical Limited through open market purchase, increasing its shareholding from 55.37% to 55.90%.
neutral
Oxygenta Pharmaceutical Seeks Shareholder Approval for Promoter ReclassificationNov 12, 2025
Oxygenta Pharmaceutical Limited has issued a postal ballot notice seeking shareholder approval to reclassify four promoter group shareholders to public shareholders. The shareholders seeking reclassification are Mr. Sai Sudhakar Vankineni (30,000 shares), Ms. Snigdha Vankineni (543,000 shares), Mr. Sumanth Simha Vankineni (343,700 shares), and Mrs. Jhansi Rani Vankineni (26,000 shares), collectively holding 942,700 shares representing 2.55% of paid-up capital. The company received applications from these shareholders on August 19, 2025, and obtained board approval on August 25, 2025. BSE Limited granted no-objection for the reclassification on October 16, 2025. The e-voting period runs from November 12, 2025 at 9:00 AM to December 11, 2025 at 5:00 PM, with results to be declared within two working days. The outgoing promoters have confirmed they will not hold more than 10% equity, exercise control, have special rights, be represented on the board, or act as key managerial personnel post-reclassification.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,693.60
#1 4,06,351.37
37.86
#1 54,729.00
9.71
#1 10,980
16.07
37.98
5,856.50
1,55,471.67
63.26
9,712.00
18.67
2,191
-1.02
33.24
3,987.20
1,34,944.97
61.20
11,539.40
6.99
1,911
26.24
32.75
2,274.50
1,03,954.48
22.26
22,909.50
13.74
3,306
#1 37.44
47.35
1,217.30
1,01,601.09
18.27
33,741.20
16.73
5,725
-15.28
39.36
1,192.40
96,319.77
21.31
28,409.50
7.12
5,291
-57.18
26.86
864.25
86,963.77
#1 17.29
23,511.00
18.55
4,615
-0.32
41.42
1,998.50
82,499.09
45.81
12,744.20
#1 20.90
2,007
7.65
41.40
1,333.70
77,461.51
22.37
32,345.60
9.43
3,484
7.59
64.38
5,258.00
62,867.28
25.87
13,458.30
3.70
2,216
1.90
42.54
Growth Rate
Revenue Growth
178.59 %
Net Income Growth
177.14 %
Cash Flow Change
119.92 %
ROE
123.77 %
ROCE
-1,067.23 %
EBITDA Margin (Avg.)
-67.90 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
6
12
9
14
21
14
52
61
31
40
111
113
Expenses
10
17
13
17
23
22
48
59
38
49
119
130
EBITDA
-4
-4
-4
-3
-2
-8
4
2
-7
-10
-9
-17
Operating Profit %
-66 %
-34 %
-59 %
-31 %
-10 %
-57 %
7 %
2 %
-23 %
-24 %
-9 %
-23 %
Depreciation
3
1
1
1
1
1
1
2
2
3
1
3
Interest
0
1
1
1
1
1
2
1
2
2
2
5
Profit Before Tax
-7
-6
-6
-5
-4
-6
3
-1
-11
-14
-12
-25
Tax
-1
0
0
0
-0
-0
0
0
0
-10
-2
0
Net Profit
-6
-6
-6
-5
-3
-6
3
-1
-12
-4
-10
-18
EPS in ₹
-5.99
-5.39
-5.69
-4.44
-3.19
-5.67
2.87
-0.48
-8.15
-1.09
-2.69
-4.90

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
18
20
19
17
21
19
34
31
54
63
83
Fixed Assets
12
13
12
12
12
11
16
20
28
29
40
Current Assets
5
5
6
4
9
7
16
10
25
24
31
Capital Work in Progress
0
0
0
0
0
0
1
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
7
7
6
5
9
7
17
11
26
34
44
Total Equity & Liabilities
18
20
19
17
21
19
34
31
54
63
83
Current Liabilities
16
21
17
20
18
17
18
8
33
34
86
Non Current Liabilities
19
21
29
29
38
43
54
58
68
50
23
Total Equity
-16
-22
-27
-32
-35
-41
-38
-35
-46
-20
-25
Reserve & Surplus
-26
-32
-38
-42
-45
-51
-48
-49
-60
-54
-62
Share Capital
10
10
10
10
10
10
10
14
14
34
37

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
-0
0
0
0
0
0
-0
-0
0
0
Investing Activities
1
-2
-1
-0
-1
-1
-7
-5
-10
-4
-11
Operating Activities
-4
1
1
1
-8
-3
-2
-2
-2
-13
3
Financing Activities
3
1
0
-1
8
3
9
6
11
17
9

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
17.17 %
17.17 %
12.33 %
12.33 %
12.33 %
12.33 %
12.33 %
12.33 %
8.99 %
26.80 %
29.73 %
29.73 %
29.73 %
33.69 %
53.28 %
51.12 %
51.12 %
57.95 %
57.95 %
55.93 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.10 %
0.10 %
0.07 %
0.07 %
0.07 %
0.07 %
0.07 %
0.07 %
0.07 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
65.52 %
65.56 %
50.63 %
50.58 %
50.69 %
50.70 %
50.72 %
50.71 %
52.89 %
57.05 %
53.65 %
53.17 %
53.31 %
50.30 %
41.81 %
43.93 %
43.93 %
36.61 %
36.55 %
38.90 %
Others
17.22 %
17.18 %
36.96 %
37.02 %
36.91 %
36.89 %
36.88 %
36.89 %
38.05 %
16.13 %
16.60 %
17.08 %
16.94 %
15.98 %
4.89 %
4.93 %
4.93 %
5.41 %
5.47 %
5.14 %
No of Share Holders
8,762
8,762
8,755
8,873
9,038
9,004
9,000
9,101
8,995
8,987
8,972
9,051
10,102
9,975
10,154
10,111
10,030
10,094
10,179
10,215

Announcements

Closure of Trading Window9 days ago
Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 20, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 14, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 13, 2026
Un-Audited Results For The Quarter And Nine Months Ended 31.12.2025.Feb 04, 2026
Board Meeting Outcome for Outcome Of Board Meeting Dated 04.02.2026.Feb 04, 2026
Board Meeting Intimation for 1. Un-Audited Financial Results For The Quarter Ended December 31 2025. 2. Limited Review Report For The Quarter Ended December 31 2025. 3. Any Other Business With The Permission Of The Chair.Jan 30, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Closure of Trading WindowDec 29, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 17, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 17, 2025
Intimation Under Regulation 30 The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (SEBI Listing Regulations) To Stock Exchanges Regarding Approval Of The Shareholders For Reclassification Of Person(S) Forming Part Of ThDec 11, 2025
Minutes Of The Resolutions Passed By Way Of Postal BallotDec 11, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportDec 11, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotDec 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2025
Intimation Of Calendar Of Events For The Postal Ballot Process Under Regulations 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Nov 11, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotNov 11, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementNov 07, 2025
Un Audited Financial Results For The Quarter And Half Year Ended 30.09.2025Nov 07, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 07.11.2025Nov 07, 2025
Board Meeting Intimation for 1. Un-Audited Financial Results For The Quarter And Half Year Ended September 30 2025. 2. Limited Review Report For The Quarter Ended September 30 2025. 3. Any Other Business With The Permission Of The Chair.Nov 03, 2025
Disclosure Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 22, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 18, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 18, 2025
Announcement Under Regulation 30Oct 16, 2025
Closure of Trading WindowSep 26, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 19, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 19, 2025
Intimation Of Submission Of Application For Reclassification Of Person Forming Part Of The Promoter / Promoter Group From Promoter Group Category To Public Category Shareholder Of The Company Pursuant To Regulation 31A Of Securities And Exchange Board Of Aug 29, 2025
Intimation Of Book Closure And Cut-Off Date For The 32Nd Annual General Meeting Of Oxygenta Pharmaceutical LimitedAug 28, 2025
Reg. 34 (1) Annual Report.Aug 28, 2025
32Nd Annual General Meeting To Be Held On Friday 19Th September 2025.Aug 28, 2025
Intimation Under Regulation 31A Of The SEBI (LODR) Regulations 2015 For Reclassification From Promoter /Promoter Group To PublicAug 25, 2025
Board Meeting Outcome for Outcome Of Board Meeting And Other Matters Under Regulations 30 And 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 25, 2025
Intimation Of Receipt Of Request Applications From Promoters For Reclassification In Accordance With Regulation 31A Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (SEBI Listing RAug 19, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 19, 2025
Announcement under Regulation 30 (LODR)-Resignation of Managing DirectorAug 18, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 18, 2025
Appointment of Company Secretary and Compliance OfficerAug 14, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerAug 14, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 14, 2025
Quarterly Results For The Quarter Ended 30.06.2025.Aug 14, 2025
Board Meeting Outcome for Outcome Of Board Meeting For The Un-Audited Financial Results For Quarter Ended 30.06.2025 And Other Matters Under Regulations 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 14, 2025
Board Meeting Intimation for The Meeting To Be Held On 14.08.2025Aug 11, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 21, 2025
Closure of Trading WindowJun 30, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jun 23, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJun 21, 2025
Intimation Under Regulation 31A (10) Relating To Reclassification Of Promoter/Promoter Group Category To Public Category Pursuant To Open Offer.Jun 20, 2025

Technical Indicators

RSI(14)
Neutral
49.12
ATR(14)
Volatile
3.69
STOCH(9,6)
Neutral
26.23
STOCH RSI(14)
Neutral
76.64
MACD(12,26)
Bullish
0.23
ADX(14)
Weak Trend
11.79
UO(9)
Bearish
40.31
ROC(12)
Downtrend And Accelerating
-2.95
WillR(14)
Neutral
-48.44